CLX Earnings & Financial Statements
The Clorox Company
$84.97
+$0.52(+0.62%)
42
Overall
80
Value
18
Tech
28
Quality
Market Cap
$10.28B
Volume
2.35M
52W Range
$79.12 - $128.90
Target Price
$95.06
CLX earnings and financial statements: The Clorox Company's income statement, balance sheet and cash flow statement, annual and quarterly.
CLX Annual Financial Statements
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $6.72B | $7.10B | $7.09B | $7.39B | $7.11B |
| Cost of revenue | -$3.88B | -$3.89B | $4.04B | $4.48B | $4.56B |
| Operating income | $12.53B | $13.01B | $923.00M | $853.00M | $750.00M |
| EBITDA | $500.00M | $555.00M | $963.00M | $564.00M | $937.00M |
| Net income | $587.00M | $810.00M | $280.00M | $149.00M | $462.00M |
| EPS (diluted) | $4.81 | $6.52 | $2.25 | $1.20 | $3.73 |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total assets | $7.79B | $5.56B | $5.75B | $5.95B | $6.16B |
| Total liabilities | $7.54B | $5.08B | $5.26B | $5.56B | $5.43B |
| Shareholders’ equity | $90.00M | $321.00M | $328.00M | $220.00M | $556.00M |
| Cash and equivalents | $143.00M | $167.00M | $202.00M | $367.00M | $183.00M |
| Long-term debt | $4.35B | $2.79B | $2.81B | $2.79B | $2.79B |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating cash flow | $612.00M | $981.00M | $695.00M | $1.16B | $786.00M |
| Capital expenditure | -$207.00M | -$220.00M | -$212.00M | -$228.00M | -$251.00M |
| Free cash flow | $405.00M | $761.00M | $483.00M | $930.00M | $535.00M |
| Dividends paid | $618.00M | $618.00M | $611.00M | $598.00M | $586.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLX | $84.97 | +0.6% | 2.35M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |